Product Details for ANDA 040415
WARFARIN SODIUM (WARFARIN SODIUM)
1MG
Marketing Status: Discontinued
2MG
Marketing Status: Discontinued
2.5MG
Marketing Status: Discontinued
3MG
Marketing Status: Discontinued
4MG
Marketing Status: Discontinued
5MG
Marketing Status: Discontinued
6MG
Marketing Status: Discontinued
7.5MG
Marketing Status: Discontinued
10MG
Marketing Status: Discontinued
1MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 001
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 001
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
2MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 002
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 002
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
2.5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 003
Approval Date: Sep 29, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 003
Approval Date: Sep 29, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
3MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 004
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 004
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
4MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 005
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 005
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 006
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 006
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
6MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 007
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 007
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
7.5MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 008
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
WARFARIN SODIUM (WARFARIN SODIUM)
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 008
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG
Marketing Status: Discontinued
Active Ingredient: WARFARIN SODIUM
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 009
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: WARFARIN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A040415
Product Number: 009
Approval Date: Sep 27, 2004
Applicant Holder Full Name: AUROBINDO PHARMA USA INC
Marketing Status: Discontinued
Patent and Exclusivity Information